Cargando…
How I treat unique and difficult-to-manage cases of CAR T-cell therapy–associated neurotoxicity
With growing indications for chimeric antigen receptor (CAR) T-cell therapy, toxicity profiles are evolving. There is an urgent and unmet need of approaches to optimally manage emerging adverse events that extend beyond the standard paradigm of cytokine release syndrome and immune effector cell-asso...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329188/ https://www.ncbi.nlm.nih.gov/pubmed/36877916 http://dx.doi.org/10.1182/blood.2022017604 |